CBIO
Crescent Biopharma, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Fund move
Fund move
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
No thesis.
Linked news
NewsCrescent Biopharma, Inc.
13.55
+0.07 · +0.50%
post 12.91 −4.67%
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | FMRFMR | $74.4M | 14.20% | 0.00% | |
| 2 | BVFBVF | $49.5M | 9.44% | 0.00% | |
| 3 | Fairmount Funds ManagementFairmount Funds | $49.5M | 9.44% | 0.00% | |
| 4 | VR AdviserVR Adviser | $38.4M | 7.33% | 0.00% | |
| 5 | Logos Global ManagementLogos Global | $34.2M | 6.53% | +293.78% | |
| 6 | Fcpm III Services B.V.Fcpm III Services B.V. | $30.2M | 5.76% | 0.00% | |
| 7 | Balyasny Asset ManagementBalyasny | $29.9M | 5.71% | +10.12% | |
| 8 | Vestal Point CapitalVestal Point Capital | $29.3M | 5.60% | +8.67% | |
| 9 | Opaleye ManagementOpaleye | $23.7M | 4.53% | +0.51% | |
| 10 | BlackRockBlackRockindex-like | $22.9M | 4.37% | +998.95% | |
| 11 | Tang Capital ManagementTang | $20.9M | 3.98% | 0.00% | |
| 12 | Vanguard Capital ManagementVanguardindex-like | $13.8M | 2.64% | −4.20% | |
| 13 | Millennium ManagementMillennium | $7.3M | 1.39% | +24.82% | |
| 14 | Geode Capital ManagementGeodeindex-like | $6.9M | 1.32% | +269.00% | |
| 15 | Jennison AssociatesJennison | $6.8M | 1.30% | +147.43% | |
| 16 | RTW InvestmentsRTW | $6.7M | 1.28% | 0.00% | |
| 17 | NEXTBio Capital ManagementNEXTBio | $6.7M | 1.28% | 0.00% | |
| 18 | Remedium Capital PartnersRemedium Capital Partners | $6.5M | 1.24% | new | |
| 19 | State StreetState Streetindex-like | $5.7M | 1.08% | +707.81% | |
| 20 | Ameriprise FinancialAmeriprise Financial | $5.4M | 1.04% | new | |
| 21 | Point72 Asset ManagementPoint72 | $5.4M | 1.03% | 0.00% | |
| 22 | T. Rowe Price AssociatesT. Rowe Price | $5.0M | 0.95% | −9.21% | |
| 23 | Marshall WaceMarshall Wace | $3.9M | 0.74% | +6.73% | |
| 24 | Perceptive AdvisorsPerceptive | $3.7M | 0.71% | 0.00% | |
| 25 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $3.4M | 0.65% | new |
80 managers report $524.0M of Crescent Biopharma on form 13F for the quarter ended Jun 30 '26. 13 of them hold 80% of it; FMR is largest at 14.20%.
Expected move
No implied move.
No implied move.
No implied move.